Concepedia

Lyndsey A. Whitlock

LA

Statistics

Publications

6

Citations

411

H-Index

6

Active since

2008

Affiliations

Pfizer (United Kingdom)(Current)

Medizinische Hochschule Hannover

Lyndsey A. Whitlock is an author at Pfizer (United Kingdom) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.

Publications per year

2008–2018

6

Publications

6

Efficacy and safety of the histamine H4 receptor antagonist ZPL-3893787 in patients with atopic dermatitis

Thomas Werfel, Gary Layton, Michael Yeadon et al. · Journal of Allergy and Clinical Immunology · 2018 · 134 citations

, , +14

Assessment of the absorption, metabolism and absolute bioavailability of maraviroc in healthy male subjects

Deborah Russell, Lyndsey A. Whitlock, Caroline E. Ridgway et al. · British Journal of Clinical Pharmacology · 2008 · 98 citations · Full text

, , +13

Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers

Timothy M. Jenkins, Lyndsey A. Whitlock, Caroline E. Ridgway et al. · British Journal of Clinical Pharmacology · 2008 · 86 citations · Full text

, , +9

Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/ zidovudine, and ethinyloestradiol/ levonorgestrel in healthy volunteers

Deborah Russell, Lyndsey A. Whitlock, Caroline E. Ridgway et al. · British Journal of Clinical Pharmacology · 2008 · 57 citations · Full text

, , +12

The effects of cotrimoxazole or tenofovir co‐administration on the pharmacokinetics of maraviroc in healthy volunteers

Deborah Russell, Lyndsey A. Whitlock, Caroline E. Ridgway et al. · British Journal of Clinical Pharmacology · 2008 · 21 citations · Full text

, , +10

1–5 of 6